Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000414295 | SCV000491067 | likely pathogenic | not provided | 2015-09-19 | criteria provided, single submitter | clinical testing | The D620G variant in the SOS1 gene has not been published as a pathogenic variant, nor has it been reported as a benign polymorphism to our knowledge. The D620G variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The D620G variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. A missense variant in a nearby residue (F623I) has been reported in the Human Gene Mutation Database in association with Noonan syndrome (Stenson et al., 2014), supporting the functional importance of this region of the protein. The D620G variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded. |